Presentation is loading. Please wait.

Presentation is loading. Please wait.

William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E

Published byDewi Kurnia Modified over 5 years ago

Similar presentations

Presentation on theme: "William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E"— Presentation transcript:

1 Inflammatory Response After Neonatal Cardiac Surgery and Its Relationship to Clinical Outcomes 
William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E. Kogon, MD, Shannon E.G. Hamrick, MD, Matthew J. Strickland, PhD  The Annals of Thoracic Surgery  Volume 97, Issue 3, Pages (March 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 (A) Box plot of log-transformed interleukin (IL)-8 concentrations measured at 6 time points. (B) Box plot of log-transformed tumor necrosis factor (TNF)-alpha concentrations measured at 6 time points. (C) Box plot of log-transformed interleukin (IL)-6 concentrations measured at 6 time points. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E"

Similar presentations

Giant Transdiaphragmatic Intercostal Hernia

Giant Transdiaphragmatic Intercostal Hernia
Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting  Amr F. Barakat, MD, Marwan Saad, MD, PhD, Ahmed Abuzaid, MD, Amgad.

Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting  Amr F. Barakat, MD, Marwan Saad, MD, PhD, Ahmed Abuzaid, MD, Amgad.
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Kanika Trehan, MD, Xun Zhou, MD, Stephen C. Yang, MD 

Kanika Trehan, MD, Xun Zhou, MD, Stephen C. Yang, MD 
Investigating the Causes of Adverse Events

Investigating the Causes of Adverse Events
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Georges Makhoul, MD, MS, Ray C.J. Chiu, MD, PhD, Renzo Cecere, MD, MS 

Georges Makhoul, MD, MS, Ray C.J. Chiu, MD, PhD, Renzo Cecere, MD, MS 
C. Wesley Lindsey, MD, W. James Parks, MD, Brian E

C. Wesley Lindsey, MD, W. James Parks, MD, Brian E
50th Anniversary Landmark Commentary on Bove EL, Behrendt DM

50th Anniversary Landmark Commentary on Bove EL, Behrendt DM
Andrew D. Shaw, MB, Ara A. Vaporciyan, MD, Xifeng Wu, MD, Terri M

Andrew D. Shaw, MB, Ara A. Vaporciyan, MD, Xifeng Wu, MD, Terri M
Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava

Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R

Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R
Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality  Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.

Surgery in Adults With Congenital Heart Disease: Risk Factors for Morbidity and Mortality  Brian Kogon, MD, Joanna Grudziak, MA, Anurag Sahu, MD, Maan.
FDA Perspective on Clinical Trial Design for Cardiovascular Devices

FDA Perspective on Clinical Trial Design for Cardiovascular Devices
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 

Similar presentations

Ads by Google